p-chloromercuribenzoic acid has been researched along with thenoyltrifluoroacetone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berridge, MV; Tan, AS | 1 |
Getoff, N; Goldenberg, H; Krajnik, P; Mao, Y; Schweinzer, E | 1 |
2 other study(ies) available for p-chloromercuribenzoic acid and thenoyltrifluoroacetone
Article | Year |
---|---|
Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction.
Topics: Animals; Antimycin A; Bone Marrow; Cell Line; Chloromercuribenzoates; Chlorpromazine; Coloring Agents; Cytochrome c Group; Electron Transport; Electron Transport Complex IV; Lysosomes; Mice; Mice, Inbred C3H; Mitochondria; NAD; NADP; Oxidation-Reduction; p-Chloromercuribenzoic Acid; Succinates; Succinic Acid; Tetrazolium Salts; Thenoyltrifluoroacetone; Thiazoles | 1993 |
Reduction of extracellular dehydroascorbic acid by K562 cells.
Topics: Ascorbic Acid; Chelating Agents; Chloromercuribenzoates; Dehydroascorbic Acid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethylmaleimide; Free Radicals; Humans; Leukemia, Erythroblastic, Acute; Leukocytes; p-Chloromercuribenzoic Acid; Thenoyltrifluoroacetone; Tumor Cells, Cultured | 1996 |